11
H index
13
i10 index
587
Citations
David Parkin : Citation Profile
Office of Health Economics (50% share) | RESEARCH PRODUCTION: 25 Articles 12 Papers 1 Books RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
35 years (1985 - 2020). Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with David Parkin. | Is cited by:
| Cites to:
|
Main data
Where David Parkin has published?
| Journals with more than one article published | # docs |
|---|---|
| Health Economics | 10 |
| Health Policy | 4 |
| Social Science & Medicine | 3 |
| Medical Decision Making | 3 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| Working Papers / Centre for Health Economics, University of York | 2 |
Recent works citing David Parkin (2023 and 2022)
| Year | Title of citing document |
|---|---|
| 2022 | Health expenditure, life expectancy, fertility rate, CO2 emissions and economic growth Do public, private and external health expenditure matter?. (2022). Sabra, Mahmoud M. In: Theoretical and Applied Economics. RePEc:agr:journl:v:3(632):y:2022:i:3(632):p:89-102. Full description at Econpapers || Download paper |
| 2022 | Health expenditure, life expectancy, fertility rate, CO2 emissions and economic growth Do public, private and external health expenditure matter. (2022). Sabra, Mahmoud. In: International Journal of Economic Sciences. RePEc:aop:jijoes:v:11:y:2022:i:2:p:179-191. Full description at Econpapers || Download paper |
| 2022 | UNDERFUNDING OF THE HEALTH SYSTEM IN ROMANIA. (2022). Alma, Pentescu ; Sebastian, Mezei. In: Revista Economica. RePEc:blg:reveco:v:74:y:2022:i:3:p:71-81. Full description at Econpapers || Download paper |
| 2022 | How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence. (2022). Boes, Stefan ; Wettstein, Dominik J. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:2:p:112-121. Full description at Econpapers || Download paper |
| 2022 | The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055. Full description at Econpapers || Download paper |
| 2022 | Is higher quality always costly? Marginal costs of quality: Theory and application to railway punctuality. (2022). Cabral, Manuel Ojeda. In: Transportation Research Part A: Policy and Practice. RePEc:eee:transa:v:157:y:2022:i:c:p:258-273. Full description at Econpapers || Download paper |
| 2022 | The relevance of including future healthcare costs in cost-effectiveness threshold calculations for the UK NHS. (2021). Perry-Duxbury, Megan ; van Baal, Pieter ; Asaria, Miqdad ; Lomas, James. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:112503. Full description at Econpapers || Download paper |
| 2022 | . Full description at Econpapers || Download paper |
| 2022 | . Full description at Econpapers || Download paper |
| 2022 | US Health Care Expenditures, GDP and Health Policy Reforms: Evidence from End-of-Sample Structural Break Tests. (2022). Woodward, Robert S ; Ozabaci, Deniz ; Conway, Karen Smith ; Brewer, Ben. In: Eastern Economic Journal. RePEc:pal:easeco:v:48:y:2022:i:4:d:10.1057_s41302-022-00218-x. Full description at Econpapers || Download paper |
| 2022 | Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment. (2022). Faria, Rita ; Ochalek, Jessica ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00679-9. Full description at Econpapers || Download paper |
| 2022 | Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers. (2022). Afzali, Hossein ; Partington, Andrew ; Karnon, Jonathan. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00681-1. Full description at Econpapers || Download paper |
| 2022 | Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents. (2022). Burstrom, Kristina ; Rolfson, Ola. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00713-w. Full description at Econpapers || Download paper |
| 2022 | Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy. (2022). Hughes, Dyfrig A ; Garcia-Lorenzo, Borja ; Devlin, Nancy ; Cubi-Molla, Patricia ; Chalkidou, Kalipso ; Cairns, John ; Watson, Sam ; Zamora, Bernarda ; Sampson, Chris ; Towse, Adrian ; Leech, Ashley A. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:5:d:10.1007_s40258-022-00730-3. Full description at Econpapers || Download paper |
| 2022 | Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression. (2022). Poder, Thomas G ; Christian, . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:2:d:10.1007_s10198-021-01364-3. Full description at Econpapers || Download paper |
| 2023 | Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7. Full description at Econpapers || Download paper |
| 2023 | Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries. (2023). Efthymiadou, Olina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01526-x. Full description at Econpapers || Download paper |
| 2022 | The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS. (2022). Asaria, Miqdad ; Baal, Pieter ; Lomas, James ; Perry-Duxbury, Megan. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-021-01090-x. Full description at Econpapers || Download paper |
| 2022 | A Comparison of PROPr and EQ-5D-5L Value Sets. (2022). Devlin, Nancy ; Viney, Rosalie ; Mulhern, Brendan ; Pan, Tianxin ; Hanmer, Janel ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:3:d:10.1007_s40273-021-01109-3. Full description at Econpapers || Download paper |
| 2022 | Analyzing the Efficiency of Working Capital Management: a New Approach Based on DEA-Malmquist Technology. (2022). Mourad, Nahia ; Habib, Ahmed Mohamed. In: SN Operations Research Forum. RePEc:spr:snopef:v:3:y:2022:i:3:d:10.1007_s43069-022-00155-7. Full description at Econpapers || Download paper |
Works by David Parkin:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2011 | Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers. [Full Text][Citation analysis] | paper | 21 |
| 2013 | TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK?ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 21 | article | |
| 2013 | The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers. [Full Text][Citation analysis] | paper | 29 |
| 2015 | The Influence of Cost?Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 29 | article | |
| 1991 | Chiropody and the QALY: a case study in assigning categories of disability and distress to patients In: Health Policy. [Full Text][Citation analysis] | article | 5 |
| 1995 | Clearing the fog on the Tyne: programme budgeting in Newcastle and North Tyneside Health Authority In: Health Policy. [Full Text][Citation analysis] | article | 7 |
| 1997 | Less fog on the Tyne? Programme budgeting in Newcastle and North Tyneside In: Health Policy. [Full Text][Citation analysis] | article | 3 |
| 2009 | Searching for cost effectiveness thresholds in the NHS In: Health Policy. [Full Text][Citation analysis] | article | 31 |
| 1987 | Aggregate health care expenditures and national income : Is health care a luxury good? In: Journal of Health Economics. [Full Text][Citation analysis] | article | 148 |
| 1985 | The demand for dental care: An assessment In: Social Science & Medicine. [Full Text][Citation analysis] | article | 4 |
| 2019 | Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study In: Social Science & Medicine. [Full Text][Citation analysis] | article | 3 |
| 2004 | Use of a visual analogue scale in a daily patient diary: modelling cross-sectional time-series data on health-related quality of life In: Social Science & Medicine. [Full Text][Citation analysis] | article | 4 |
| 2014 | Towards Earlier Discharge, Better Outcomes, Lower Cost: Stroke Rehabilitation in Ireland In: Research Series. [Full Text][Citation analysis] | book | 1 |
| 2000 | Costs and Quality of Life in Multiple Sclerosis. A Cross-Sectional Observational Study in the UK In: SSE/EFI Working Paper Series in Economics and Finance. [Full Text][Citation analysis] | paper | 19 |
| 2009 | Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science. [Full Text][Citation analysis] | article | 33 |
| 2013 | The Influence of Cost-effectiveness and Other Factors on NICE Decisions In: Research Paper. [Full Text][Citation analysis] | paper | 7 |
| 2012 | Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Paper. [Full Text][Citation analysis] | paper | 2 |
| 2011 | Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Paper. [Full Text][Citation analysis] | paper | 3 |
| 2014 | What Determines the Shape of an EQ-5D Index Distribution? In: Research Paper. [Full Text][Citation analysis] | paper | 7 |
| 2016 | The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Paper. [Full Text][Citation analysis] | paper | 0 |
| 2018 | New Methods for Analysing the Distribution of EQ-5D Observations In: Research Paper. [Full Text][Citation analysis] | paper | 2 |
| 2019 | Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Paper. [Full Text][Citation analysis] | paper | 0 |
| 2020 | Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? In: Research Paper. [Full Text][Citation analysis] | paper | 2 |
| 1989 | Comparing Health Service Efficiency Across Countries. In: Oxford Review of Economic Policy. [Citation analysis] | article | 1 |
| 2002 | Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices In: MPRA Paper. [Full Text][Citation analysis] | paper | 16 |
| 2010 | Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? In: Medical Decision Making. [Full Text][Citation analysis] | article | 8 |
| 2016 | What Determines the Shape of an EQ-5D Index Distribution? In: Medical Decision Making. [Full Text][Citation analysis] | article | 2 |
| 2020 | Using EQ-5D Data to Measure Hospital Performance: Are General Population Values Distorting Patients’ Choices? In: Medical Decision Making. [Full Text][Citation analysis] | article | 0 |
| 2003 | A single European currency for EQ-5D health states In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 11 |
| 1997 | Measuring production efficiency of acute hospitals in Scotland, 1991-94: validity issues in data envelopment analysis In: Applied Economics. [Full Text][Citation analysis] | article | 38 |
| 2002 | Recognising diversity in public preferences: the use of preference sub?groups in cost?effectiveness analysis. A response to Sculpher and Gafni In: Health Economics. [Full Text][Citation analysis] | article | 6 |
| 2004 | Does NICE have a cost?effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics. [Full Text][Citation analysis] | article | 112 |
| 2006 | Is there a case for using visual analogue scale valuations in cost?utility analysis? In: Health Economics. [Full Text][Citation analysis] | article | 33 |
| 2007 | ‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2010 | Patient?reported outcome measures in the NHS: new methods for analysing and reporting EQ?5D data In: Health Economics. [Full Text][Citation analysis] | article | 10 |
| 2015 | INTER?PROVIDER COMPARISON OF PATIENT?REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics. [Full Text][Citation analysis] | article | 2 |
| 1995 | Investigating hospital efficiency in the new NHS: The role of the translog cost function In: Health Economics. [Full Text][Citation analysis] | article | 14 |
| 1999 | Non? and semi?parametric estimation of age and time heterogeneity in repeated cross?sections: an application to self?reported morbidity and general practitioner utilization1 In: Health Economics. [Full Text][Citation analysis] | article | 3 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 3 2023. Contact: CitEc Team